Phase 1 Psoriatic Arthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years old or older and able to give your own consent to participate
- You have been diagnosed with active psoriatic arthritis or axial spondyloarthritis (a type of inflammatory spinal condition), and your doctor considers the study drug bimekizumab an appropriate treatment option for you
- Your weight falls within a specific range: between 45–100 kg if you are female, or between 50–100 kg if you are male
- You have never used biologic medications for your condition, OR you stopped taking biologic medications at least 3 months ago (or long enough for the medication to clear your system)
Who may not be able to join:
- You have serious problems affecting major organs such as your heart, liver, kidneys, digestive system, or nervous system
- You have had severe mental health difficulties or problems with substance misuse in the past year
- You have a current, recent, or long-standing infection, including tuberculosis (TB) or a related type of bacterial infection
- You have another inflammatory condition such as rheumatoid arthritis, lupus, or inflammatory bowel disease
- You have received a live vaccine in the past 8 weeks, or a BCG vaccine (commonly given for TB prevention) in the past year
- You have used a GLP-1 medication (a type of drug often used for diabetes or weight management) within the past 28 weeks
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: UCB Cares, 001 844 599 22733 (UCB)
Phone: +18445992273
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Steady-state Trough Concentration (Ctrough,ss) at Week 16
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.